Gadoquatrane
Contrast agent
From Wikipedia, the free encyclopedia
Gadoquatrane, sold under the brand name Ambelvist, is a macrocylic gadolinium-based MRI contrast agent (mGBCA) that is used with contrast-enhanced magnetic resonance imaging (CE-MRI)[2] to detect and visualize lesions with abnormal vascularity in certain parts of the body.[3] Gadoquatrane is administered as an intravenous injection.
Trade namesAmbelvist
ATC code
- None
| Clinical data | |
|---|---|
| Trade names | Ambelvist |
| License data |
|
| Routes of administration | Intravenous |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C81H128Gd4N24O32 |
| Molar mass | 2579.05 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Medical uses
Society and culture
Legal status
Gadoquatrane was approved for medical use in the United States in June 2026.[4]
Names
Gadoquatrane is the international nonproprietary name.[5]
Gadoquatrane is sold under the brand name Ambelvist.[1]